Stock Analysis

Scientific and Medical Equipment House Full Year 2023 Earnings: EPS: ر.س1.34 (vs ر.س0.59 in FY 2022)

SASE:4014
Source: Shutterstock

Scientific and Medical Equipment House (TADAWUL:4014) Full Year 2023 Results

Key Financial Results

  • Revenue: ر.س799.3m (up 12% from FY 2022).
  • Net income: ر.س40.1m (up 128% from FY 2022).
  • Profit margin: 5.0% (up from 2.5% in FY 2022). The increase in margin was driven by higher revenue.
  • EPS: ر.س1.34 (up from ر.س0.59 in FY 2022).
earnings-and-revenue-history
SASE:4014 Earnings and Revenue History April 5th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Scientific and Medical Equipment House Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Healthcare industry in Saudi Arabia.

Performance of the Saudi Healthcare industry.

The company's shares are down 3.8% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 3 warning signs for Scientific and Medical Equipment House that you need to be mindful of.

Valuation is complex, but we're helping make it simple.

Find out whether Scientific and Medical Equipment House is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.